SGMO – sangamo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy
How Recent Developments Are Rewriting the Story for Sangamo Therapeutics [Yahoo! Finance]
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease [Yahoo! Finance]
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
Sangamo Therapeutics (NASDAQ:SGMO) was downgraded by analysts at Wall St
Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Jain Nikunj
Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Willoughby Scott B.
Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Macrae Sandy
Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Duraibabu Prathyusha
Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Dubois-Stringfellow Nathalie
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.